Price11.00%   -0.0583

Axcella Health Inc (AXLA) Stock Discussions on Social Media

- AXLA Stock on Twitter: https://twitter.com/search?q=$axla
- AXLA Stock on Reddit: https://www.reddit.com/search/?q=$axla
- AXLA Stock on SeekingAlpha: https://seekingalpha.com/symbol/AXLA
Axcella Health Inc., a biotechnology company, researches and develops novel multifactorial interventions to support health and address dysregulated metabolism in the United States. The company develops its products based on its AXA Development Platform. It offers AXA1665 for use in treating hepatic encephalopathy; AXA1125 and AXA1957 to treat non-alcoholic fatty liver disease; AXA2678 for use in treating immobilization-induced acute muscle atrophy; and AXA4010 to target multiple biological pathways. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was founded in 2008 and is based in Cambridge, Massachusetts.
Cap:    |  Volume (24h):